INOVIO Pharmaceuticals, Inc. releases its Q3 report, highlighting financial metrics and operational updates that impact the pharmaceutical preparations industry.
| Name | INOVIO PHARMACEUTICALS, INC. |
|---|---|
| CIK | 0001055726 |
| Tickers | INO |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 330969592 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 8584103134 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
INOVIO Pharmaceuticals, Inc. releases its Q3 report, highlighting financial metrics and operational updates that impact the pharmaceutical preparations industry.
Inovio Pharmaceuticals announces third-quarter results and FDA approval of VOCERYQ, marking a significant milestone for the company.
Inovio Pharmaceuticals announces a public offering of 58 million shares, aiming to raise approximately $80.5 million for its operations.
Inovio Pharmaceuticals reveals preliminary cash estimates of $48.4 million as of September 30, 2026, indicating ongoing financial health.
FMR LLC discloses a 14.5% ownership stake in INOVIO Pharmaceuticals, indicating strategic movements within the pharmaceutical sector.
Inovio Pharmaceuticals has received FDA accelerated approval for VOCERYQ, an immunotherapy for adults with Recurrent Respiratory Papillomatosis, set for launch in early 2027.
1304 filing rows loaded from submissions recent; extra archives: CIK0001055726-submissions-001.json (304 filings, 1999-06-29 to 2008-05-05).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 8-K | 8-K | 5.02 | 0001193125-26-465502 | 001-14888 | 261566059 | 34 | 140977 | 1 | 1 |
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128721 | 005-60487 | 261563788 | 34 | 16257 | |||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-014444 | 005-60487 | 261562481 | 34 | 31360 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005390 | 005-60487 | 261561964 | 34 | 10842 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-007926 | 005-60487 | 261555708 | 34 | 11258 | |||
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001055726-26-000030 | 001-14888 | 261540332 | 34 | 280654 | 1 | 1 |
| 2026-11-10 | 10-Q | 10-Q | 0001055726-26-000029 | 001-14888 | 261540153 | 34 | 9378236 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 1.01,7.01,8.01,9.01 | 0001193125-26-452658 | 001-14888 | 261533818 | 34 | 628399 | 1 | 1 |
| 2026-11-06 | 424B5 | 424B5 | 0001193125-26-451932 | 333-297233 | 261532460 | 33 | 637510 | |||
| 2026-11-06 | FWP | FWP | 0001193125-26-450394 | 333-297233 | 261529002 | 34 | 115209 | |||
| 2026-11-05 | 8-K | 8-K | 2.02 | 0001193125-26-449853 | 001-14888 | 261527497 | 34 | 141980 | 1 | 1 |
| 2026-11-05 | 424B5 | 424B5 | 0001193125-26-449837 | 333-297233 | 261527418 | 33 | 603784 | |||
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002763 | 005-60487 | 261526199 | 34 | 12238 | |||
| 2026-11-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-442648 | 001-14888 | 261509884 | 34 | 2745425 | 1 | 1 |
| 2026-10-06 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-415555 | 001-14888 | 261444069 | 34 | 151981 | 1 | 1 |
| 2026-08-12 | 8-K | 8-K | 2.02,9.01 | 0001055726-26-000024 | 001-14888 | 261267506 | 34 | 271356 | 1 | 1 |
| 2026-08-12 | 10-Q | 10-Q | 0001055726-26-000023 | 001-14888 | 261267300 | 34 | 9157890 | 1 | 1 | |
| 2026-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-004959 | 005-60487 | 261266214 | 34 | 13503 | |||
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000216 | 005-60487 | 261254150 | 34 | 20189 | |||
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002045 | 005-60487 | 261247092 | 34 | 12018 | |||
| 2026-07-31 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-001406 | 005-60487 | 261226034 | 34 | 7793 | |||
| 2026-07-31 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-26-326785 | 001-14888 | 261225419 | 34 | 684129 | 1 | 1 |
| 2026-07-30 | 424B5 | 424B5 | 0001193125-26-326370 | 333-297233 | 261224597 | 33 | 743921 | |||
| 2026-07-29 | 8-K | 8-K | 2.02 | 0001193125-26-323628 | 001-14888 | 261217318 | 34 | 137444 | 1 | 1 |
| 2026-07-29 | 424B5 | 424B5 | 0001193125-26-323616 | 333-297233 | 261217270 | 33 | 745283 | |||
| 2026-07-10 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002261 | 333-297233 | 261169844 | 33 | 2090 | ||
| 2026-07-02 | S-3 | S-3 | 0001193125-26-294457 | 333-297233 | 261150903 | 33 | 1180134 | 1 | 1 | |
| 2026-05-26 | S-8 | S-8 | 0001193125-26-237305 | 333-296207 | 261015473 | 33 | 340352 | 1 | 1 | |
| 2026-05-21 | 4 | FORM 4 | 0001181186-26-000002 | 7930 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001587788-26-000002 | 8035 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001771423-26-000001 | 8105 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001669080-26-000003 | 8043 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001278219-26-000001 | 8103 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001741836-26-000005 | 8031 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001273306-26-000001 | 8034 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001770390-26-000005 | 14850 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001936799-26-000006 | 14819 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001259780-26-000006 | 15485 | ||||||
| 2026-05-21 | 4 | FORM 4 | 0001771498-26-000005 | 14871 | ||||||
| 2026-05-20 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-26-232524 | 001-14888 | 261003845 | 34 | 174858 | 1 | 1 |
| 2026-05-18 | 4 | FORM 4 | 0001771498-26-000004 | 9203 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0001259780-26-000005 | 9823 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0001770390-26-000004 | 9191 | ||||||
| 2026-05-18 | 4 | FORM 4 | 0001936799-26-000005 | 9154 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003181 | 005-60487 | 26981855 | 34 | 9977 | |||
| 2026-05-13 | 8-K | 8-K | 2.02,9.01 | 0001055726-26-000019 | 001-14888 | 26973278 | 34 | 262383 | 1 | 1 |
| 2026-05-13 | 10-Q | 10-Q | 0001055726-26-000018 | 001-14888 | 26973084 | 34 | 8216924 | 1 | 1 | |
| 2026-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-002915 | 005-60487 | 26971202 | 34 | 13460 | |||
| 2026-05-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001216 | 005-60487 | 26946807 | 34 | 11644 | |||
| 2026-04-07 | DEF 14A | DEF 14A | 0001055726-26-000011 | 001-14888 | 26845039 | 34 | 8901309 | 1 | 1 | |
| 2026-04-06 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-26-142885 | 001-14888 | 26839545 | 34 | 808305 | 1 | 1 |
| 2026-04-02 | 424B5 | 424B5 | 0001193125-26-140421 | 333-275445 | 26834968 | 33 | 745916 | |||
| 2026-04-02 | 8-K | 8-K | 8.01 | 0001193125-26-138870 | 001-14888 | 26830512 | 34 | 136880 | 1 | 1 |
| 2026-04-02 | 424B5 | 424B5 | 0001193125-26-138636 | 333-275445 | 26830388 | 33 | 749033 | |||
| 2026-04-01 | 4 | FORM 4 | 0001936799-26-000004 | 8923 | ||||||
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001055726-26-000009 | 001-14888 | 26747688 | 34 | 271998 | 1 | 1 |
| 2026-03-12 | 10-K | 10-K | 0001055726-26-000008 | 001-14888 | 26747516 | 34 | 12070359 | 1 | 1 | |
| 2026-03-05 | 4 | FORM 4 | 0001770390-26-000003 | 8257 | ||||||
| 2026-03-05 | 4 | FORM 4 | 0001771498-26-000003 | 8266 | ||||||
| 2026-03-05 | 4 | FORM 4 | 0001936799-26-000003 | 8225 | ||||||
| 2026-03-05 | 4 | FORM 4 | 0001259780-26-000004 | 8208 | ||||||
| 2026-02-27 | 4 | FORM 4 | 0001770390-26-000002 | 14681 | ||||||
| 2026-02-27 | 4 | FORM 4 | 0001259780-26-000002 | 15319 | ||||||
| 2026-02-27 | 4 | FORM 4 | 0001771498-26-000002 | 14698 | ||||||
| 2026-02-27 | 4 | FORM 4 | 0001936799-26-000002 | 12912 | ||||||
| 2026-02-27 | 4 | FORM 4 | 0001669080-26-000002 | 7213 | ||||||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001178 | 005-60487 | 26642744 | 34 | 11000 | |||
| 2026-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000224 | 005-60487 | 26582408 | 34 | 7433 | |||
| 2026-01-27 | 424B5 | 424B5 | 0001193125-26-024500 | 333-275445 | 26565728 | 33 | 45901 | |||
| 2026-01-27 | 8-K | 8-K | 1.01,3.03,9.01 | 0001193125-26-024431 | 001-14888 | 26565652 | 34 | 149645 | 1 | 1 |
| 2025-12-29 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-332322 | 001-14888 | 251603277 | 34 | 164526 | 1 | 1 |
| 2025-12-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000337 | 005-60487 | 251555162 | 34 | 10376 | |||
| 2025-12-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002964 | 005-60487 | 251552356 | 34 | 11820 | |||
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-005183 | 005-60487 | 251489000 | 34 | 10911 | |||
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000276 | 005-60487 | 251482428 | 34 | 10934 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-004827 | 005-60487 | 251481388 | 34 | 12363 | |||
| 2025-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-004899 | 005-60487 | 251475779 | 34 | 16972 | |||
| 2025-11-12 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-275721 | 001-14888 | 251468387 | 34 | 451108 | 1 | 1 |
| 2025-11-12 | 424B5 | 424B5 | 0001193125-25-275689 | 333-275445 | 251468355 | 33 | 594043 | |||
| 2025-11-12 | 424B5 | 424B5 | 0001193125-25-274790 | 333-275445 | 251467826 | 33 | 595608 | |||
| 2025-11-10 | 8-K | 8-K | 2.02,9.01 | 0001055726-25-000064 | 001-14888 | 251466224 | 34 | 305826 | 1 | 1 |
| 2025-11-10 | 10-Q | 10-Q | 0001055726-25-000063 | 001-14888 | 251466019 | 34 | 8967317 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0001055726-25-000056 | 001-14888 | 251206708 | 34 | 323162 | 1 | 1 |
| 2025-08-12 | 10-Q | 10-Q | 0001055726-25-000055 | 001-14888 | 251206480 | 34 | 8755089 | 1 | 1 | |
| 2025-07-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003067 | 005-60487 | 251132230 | 34 | 11114 | |||
| 2025-07-07 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-155830 | 001-14888 | 251106985 | 34 | 799770 | 1 | 1 |
| 2025-07-03 | 424B5 | 424B5 | 0001193125-25-155531 | 333-275445 | 251106296 | 33 | 629643 | |||
| 2025-07-02 | 424B5 | 424B5 | 0001193125-25-154972 | 333-275445 | 251101614 | 33 | 610746 | |||
| 2025-07-01 | 4 | FORM 4 | 0001055726-25-000046 | 7284 | ||||||
| 2025-05-22 | 8-K | 8-K | 5.07 | 0001055726-25-000045 | 001-14888 | 25978251 | 34 | 178782 | 1 | 1 |
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000042 | 8152 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000041 | 8138 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000040 | 7001 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000039 | 7003 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000038 | 6933 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000037 | 6933 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000036 | 6829 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000035 | 8086 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000034 | 6929 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000033 | 8103 | ||||||
| 2025-05-21 | 4 | FORM 4 | 0001055726-25-000032 | 6942 | ||||||
| 2025-05-16 | 4 | FORM 4 | 0001055726-25-000031 | 9022 | ||||||
| 2025-05-16 | 4 | FORM 4 | 0001055726-25-000030 | 9071 | ||||||
| 2025-05-16 | 4 | FORM 4 | 0001055726-25-000029 | 9691 | ||||||
| 2025-05-16 | 4 | FORM 4 | 0001055726-25-000028 | 9059 | ||||||
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000331 | 005-60487 | 25945531 | 34 | 19592 | |||
| 2025-05-13 | 8-K | 8-K | 2.02,9.01 | 0001055726-25-000027 | 001-14888 | 25940063 | 34 | 275496 | 1 | 1 |
| 2025-05-13 | 10-Q | 10-Q | 0001055726-25-000026 | 001-14888 | 25939787 | 34 | 7856601 | 1 | 1 | |
| 2025-05-12 | 4 | FORM 4 | 0001055726-25-000020 | 9059 | ||||||
| 2025-04-30 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000647 | 005-60487 | 25892310 | 34 | 6531 | |||
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000613 | 005-60487 | 25844585 | 34 | 11119 | |||
| 2025-04-07 | ARS | ARS | 0001055726-25-000019 | 001-14888 | 25818348 | 34 | 18065108 | |||
| 2025-04-07 | DEF 14A | DEF 14A | 0001055726-25-000018 | 001-14888 | 25818210 | 34 | 12713358 | 1 | 1 | |
| 2025-03-18 | 8-K | 8-K | 2.02,9.01 | 0001055726-25-000013 | 001-14888 | 25748320 | 34 | 302096 | 1 | 1 |
| 2025-03-18 | 10-K | 10-K | 0001055726-25-000012 | 001-14888 | 25748097 | 34 | 12450086 | 1 | 1 | |
| 2025-02-28 | 4 | FORM 4 | 0001055726-25-000005 | 19392 | ||||||
| 2025-02-28 | 4 | FORM 4 | 0001055726-25-000004 | 12049 | ||||||
| 2025-02-28 | 4 | FORM 4 | 0001055726-25-000003 | 19411 | ||||||
| 2025-02-28 | 4 | FORM 4 | 0001055726-25-000002 | 19883 | ||||||
| 2025-02-28 | 4 | FORM 4 | 0001055726-25-000001 | 11364 | ||||||
| 2025-02-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000808 | 005-60487 | 25606549 | 34 | 9864 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001479 | 005-60487 | 25594533 | 34 | 12095 | |||
| 2025-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000174 | 005-60487 | 25575651 | 34 | 6691 | |||
| 2024-12-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-24-000779 | 005-60487 | 241575376 | 34 | 19847 | |||
| 2024-12-18 | 4 | FORM 4 | 0001055726-24-000055 | 7941 | ||||||
| 2024-12-16 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-279061 | 001-14888 | 241550200 | 34 | 539349 | 1 | 1 |
| 2024-12-13 | 424B5 | 424B5 | 0001193125-24-278461 | 333-275445 | 241548299 | 33 | 725063 | |||
| 2024-12-12 | 424B5 | 424B5 | 0001193125-24-277193 | 333-275445 | 241545649 | 33 | 726266 | |||
| 2024-11-14 | 8-K | 8-K | 2.02,9.01 | 0001055726-24-000053 | 001-14888 | 241462077 | 34 | 303943 | 1 | 1 |
| 2024-11-14 | 10-Q | 10-Q | 0001055726-24-000052 | 001-14888 | 241461503 | 34 | 8090284 | 1 | 1 | |
| 2024-11-08 | SC 13G | us45773h4092_110824.txt | 0002012383-24-003609 | 005-60487 | 241439770 | 34 | 13945 | |||
| 2024-10-22 | SC 13G | us45773h4092_102224.txt | 0002012383-24-001669 | 005-60487 | 241387384 | 34 | 13933 | |||
| 2024-08-13 | 424B5 | 424B5 | 0001193125-24-199348 | 333-275445 | 241198671 | 33 | 402666 | |||
| 2024-08-13 | 8-K | 8-K | 1.01,9.01 | 0001193125-24-199331 | 001-14888 | 241198635 | 34 | 377895 | 1 | 1 |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-197065 | 001-14888 | 241189439 | 34 | 252391 | 1 | 1 |
| 2024-08-08 | 10-Q | 10-Q | 0001055726-24-000046 | 001-14888 | 241188018 | 34 | 7896433 | 1 | 1 | |
| 2024-07-01 | 4 | FORM 4 | 0001055726-24-000042 | 7563 | ||||||
| 2024-05-28 | 8-K | 8-K | 5.02,5.07 | 0001193125-24-148076 | 001-14888 | 24991583 | 34 | 177218 | 1 | 1 |
| 2024-05-22 | 4 | FORM 4 | 0001055726-24-000041 | 7939 | ||||||
| 2024-05-22 | 4 | FORM 4 | 0001055726-24-000040 | 7871 | ||||||
| 2024-05-22 | 4 | FORM 4 | 0001055726-24-000039 | 7941 | ||||||
| 2024-05-22 | 4 | FORM 4 | 0001055726-24-000038 | 7879 | ||||||
| 2024-05-22 | 4 | FORM 4 | 0001055726-24-000037 | 7766 | ||||||
| 2024-05-22 | 4 | FORM 4 | 0001055726-24-000036 | 7870 | ||||||
| 2024-05-22 | 4 | FORM 4 | 0001055726-24-000035 | 7867 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000034 | 7236 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000033 | 7167 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000032 | 7166 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000031 | 9866 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000030 | 9338 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000029 | 7560 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000028 | 7175 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000027 | 7061 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000026 | 7234 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000025 | 7160 | ||||||
| 2024-05-16 | 4 | FORM 4 | 0001055726-24-000024 | 9350 | ||||||
| 2024-05-13 | 4 | FORM 4 | 0001055726-24-000023 | 7400 | ||||||
| 2024-05-13 | 4 | FORM 4 | 0001055726-24-000022 | 9338 | ||||||
| 2024-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-137228 | 001-14888 | 24939164 | 34 | 247816 | 1 | 1 |
| 2024-05-13 | 10-Q | 10-Q | 0001055726-24-000020 | 001-14888 | 24938858 | 34 | 7132862 | 1 | 1 | |
| 2024-04-26 | SC 13G | deeptrack-ino041624.htm | 0001172661-24-001942 | 005-60487 | 24883383 | 34 | 105635 | |||
| 2024-04-17 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-099067 | 001-14888 | 24850968 | 34 | 542786 | 1 | 1 |
| 2024-04-17 | 424B5 | 424B5 | 0001193125-24-099057 | 333-275445 | 24850947 | 33 | 732391 | |||
| 2024-04-15 | ARS | ARS | 0001055726-24-000017 | 001-14888 | 24845533 | 34 | 18998569 | |||
| 2024-04-11 | DEF 14A | DEF 14A | 0001055726-24-000014 | 001-14888 | 24838607 | 34 | 5066137 | |||
| 2024-03-06 | 10-K | 10-K | 0001055726-24-000011 | 001-14888 | 24725781 | 34 | 13182303 | 1 | 1 | |
| 2024-02-28 | 4 | FORM 4 | 0001055726-24-000006 | 15262 | ||||||
| 2024-02-28 | 4 | FORM 4 | 0001055726-24-000005 | 19754 | ||||||
| 2024-02-28 | 4 | FORM 4 | 0001055726-24-000004 | 19742 | ||||||
| 2024-02-28 | 4 | FORM 4 | 0001055726-24-000003 | 20273 | ||||||
| 2024-02-28 | 4 | FORM 4 | 0001055726-24-000002 | 8239 | ||||||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021192 | 005-60487 | 24628644 | 34 | 13387 | |||
| 2024-01-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-01-31 16:00:00 | 9999999995-24-000261 | 333-275445 | 24584884 | 33 | 2068 | ||
| 2024-01-29 | CORRESP | filename1.htm | 0001193125-24-018179 | 8275 | ||||||
| 2024-01-26 | S-3/A | S-3/A | 0001193125-24-016690 | 333-275445 | 24567680 | 33 | 107668 | |||
| 2024-01-25 | 8-K | 8-K | 5.03,9.01 | 0001193125-24-015380 | 001-14888 | 24562150 | 34 | 161600 | 1 | 1 |
| 2024-01-22 | SC 13G/A | Inovio_Pharma_Inc.txt | 0000093751-24-000038 | 005-60487 | 24547356 | 34 | 8633 | |||
| 2024-01-12 | 8-K | 8-K | 5.07 | 0001193125-24-007674 | 001-14888 | 24532980 | 34 | 150533 | 1 | 1 |
| 2023-11-28 | DEF 14A | DEF 14A | 0001193125-23-284277 | 001-14888 | 231446429 | 34 | 297183 | |||
| 2023-11-17 | PRE 14A | PRE 14A | 0001193125-23-279764 | 001-14888 | 231418466 | 34 | 230060 | |||
| 2023-11-16 | UPLOAD | filename1.pdf | 0000000000-23-012564 | 333-275445 | 40763 | |||||
| 2023-11-09 | S-3 | S-3 | 0001193125-23-274556 | 333-275445 | 231393191 | 33 | 998559 | |||
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-274515 | 001-14888 | 231392675 | 34 | 256914 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0001055726-23-000055 | 001-14888 | 231392106 | 34 | 8640543 | 1 | 1 | |
| 2023-11-02 | 8-K | 8-K | 3.01 | 0001193125-23-269347 | 001-14888 | 231372064 | 34 | 144990 | 1 | 1 |
| 2023-10-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-253450 | 001-14888 | 231317892 | 34 | 176332 | 1 | 1 |
| 2023-08-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-207397 | 001-14888 | 231155559 | 34 | 253626 | 1 | 1 |
| 2023-08-09 | 10-Q | 10-Q | 0001055726-23-000051 | 001-14888 | 231154960 | 34 | 8563279 | 1 | 1 | |
| 2023-08-01 | 8-K | 8-K | 2.05 | 0001193125-23-199683 | 001-14888 | 231129346 | 34 | 144146 | 1 | 1 |
| 2023-07-10 | SC 13G/A | Inovio_Pharma_Inc.txt | 0000093751-23-000630 | 005-60487 | 231079337 | 34 | 8519 | |||
| 2023-07-07 | SC 13G/A | us45773h2013_070723.txt | 0001306550-23-009603 | 005-60487 | 231077290 | 34 | 12620 | |||
| 2023-07-03 | 4 | FORM 4 | 0001055726-23-000045 | 7171 | ||||||
| 2023-06-23 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-173847 | 001-14888 | 231038042 | 34 | 448673 | 1 | 1 |
| 2023-06-05 | 4 | FORM 4 | 0001055726-23-000044 | 4880 | ||||||
| 2023-06-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-001252 | 001-14888 | 23992351 | 33 | 5034 | |||
| 2023-05-18 | S-8 | S-8 | 0001193125-23-148226 | 333-272047 | 23936725 | 33 | 64742 | |||
| 2023-05-18 | S-8 | S-8 | 0001193125-23-148215 | 333-272045 | 23936616 | 33 | 81307 | |||
| 2023-05-18 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-148122 | 001-14888 | 23936084 | 34 | 339396 | 1 | 1 |
| 2023-05-17 | 4 | FORM 4 | 0001055726-23-000043 | 5939 | ||||||
| 2023-05-17 | 4 | FORM 4 | 0001055726-23-000042 | 5978 | ||||||
| 2023-05-17 | 4 | FORM 4 | 0001055726-23-000041 | 5780 | ||||||
| 2023-05-17 | 4 | FORM 4 | 0001055726-23-000040 | 5984 | ||||||
| 2023-05-16 | 4 | FORM 4 | 0001055726-23-000039 | 11395 | ||||||
| 2023-05-16 | 4 | FORM 4 | 0001055726-23-000038 | 11222 | ||||||
| 2023-05-16 | 4 | FORM 4 | 0001055726-23-000037 | 11335 | ||||||
| 2023-05-16 | 4 | FORM 4 | 0001055726-23-000036 | 11327 | ||||||
| 2023-05-16 | 4 | FORM 4 | 0001055726-23-000035 | 11327 | ||||||
| 2023-05-16 | 4 | FORM 4 | 0001055726-23-000034 | 11397 | ||||||
| 2023-05-16 | 4 | FORM 4 | 0001055726-23-000033 | 15115 | ||||||
| 2023-05-12 | 4 | FORM 4 | 0001055726-23-000032 | 8896 | ||||||
| 2023-05-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-140755 | 001-14888 | 23906716 | 34 | 261752 | 1 | 1 |
| 2023-05-10 | 10-Q | 10-Q | 0001055726-23-000030 | 001-14888 | 23906219 | 34 | 8465106 | 1 | 1 | |
| 2023-04-03 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-23-056527,2023-04-03 | 9999999995-23-000798 | 333-252256 | 23794987 | 33 | 2009 | ||
| 2023-03-31 | DEFA14A | DEFA14A | 0001055726-23-000025 | 001-14888 | 23788221 | 34 | 201425 | |||
| 2023-03-28 | ARS | ARS | 0001055726-23-000023 | 001-14888 | 23770321 | 34 | 87748923 | |||
| 2023-03-28 | DEF 14A | DEF 14A | 0001055726-23-000022 | 001-14888 | 23770298 | 34 | 3397411 | |||
| 2023-03-28 | POS EX | POS EX | 0001193125-23-082177 | 333-252256 | 23769709 | 33 | 69101 | |||
| 2023-03-13 | 4 | FORM 4 | 0001055726-23-000014 | 8722 | ||||||
| 2023-03-13 | 4 | FORM 4 | 0001055726-23-000013 | 8932 | ||||||
| 2023-03-13 | 4 | FORM 4 | 0001055726-23-000012 | 8935 | ||||||
| 2023-03-13 | 4 | FORM 4 | 0001055726-23-000011 | 9415 | ||||||
| 2023-03-01 | POS AM | POS AM | 0001193125-23-056527 | 333-252256 | 23694786 | 33 | 300828 | |||
| 2023-03-01 | 10-K | 10-K | 0001055726-23-000010 | 001-14888 | 23694199 | 34 | 14101521 | 1 | 1 | |
| 2023-03-01 | POSASR | POSASR | 0001193125-23-056386 | 333-252256 | 23694055 | 33 | 339329 | |||
| 2023-03-01 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-056363 | 001-14888 | 23693864 | 34 | 267311 | 1 | 1 |
| 2023-02-28 | 4 | FORM 4 | 0001055726-23-000007 | 16828 | ||||||
| 2023-02-28 | 4 | FORM 4 | 0001055726-23-000006 | 16820 | ||||||
| 2023-02-28 | 4 | FORM 4 | 0001055726-23-000005 | 17306 | ||||||
| 2023-02-28 | 4 | FORM 4 | 0001055726-23-000004 | 17405 | ||||||
| 2023-02-28 | 4 | FORM 4 | 0001055726-23-000003 | 5703 | ||||||
| 2023-02-09 | SC 13G/A | Inovio_Pharmaceuticals_Inc.txt | 0000093751-23-000396 | 005-60487 | 23605785 | 34 | 10679 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016201 | 005-60487 | 23603460 | 34 | 13290 | |||
| 2023-01-31 | 8-K | 8-K | 2.05,7.01,8.01,9.01 | 0001193125-23-019738 | 001-14888 | 23570285 | 34 | 182274 | 1 | 1 |
| 2023-01-24 | SC 13G/A | us45773h2013_012423.txt | 0001306550-23-003092 | 005-60487 | 23547482 | 34 | 13673 | |||
| 2023-01-17 | 4 | FORM 4 | 0001055726-23-000001 | 7102 | ||||||
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-280159 | 001-14888 | 221369047 | 34 | 247687 | 1 | 1 |
| 2022-11-08 | 10-Q | 10-Q | 0001055726-22-000055 | 001-14888 | 221368712 | 34 | 9417057 | 1 | 1 | |
| 2022-10-14 | UPLOAD | filename1.pdf | 0000000000-22-011338 | 40001 | ||||||
| 2022-09-29 | CORRESP | filename1.htm | 0001193125-22-254501 | 56175 | ||||||
| 2022-09-15 | UPLOAD | filename1.pdf | 0000000000-22-010123 | 45304 | ||||||
| 2022-08-11 | 4 | FORM 4 | 0001055726-22-000050 | 9004 | ||||||
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-216168 | 001-14888 | 221148611 | 34 | 257170 | 1 | 1 |
| 2022-08-09 | 10-Q | 10-Q | 0001055726-22-000049 | 001-14888 | 221148053 | 34 | 9554265 | 1 | 1 | |
| 2022-07-20 | 4 | FORM 4 | 0001055726-22-000045 | 8478 | ||||||
| 2022-07-19 | 8-K | 8-K | 2.05,7.01,9.01 | 0001193125-22-196671 | 001-14888 | 221090474 | 34 | 179104 | 1 | 1 |
| 2022-07-06 | 4 | FORM 4 | 0001055726-22-000044 | 8128 | ||||||
| 2022-07-06 | 3 | FORM 3 | 0001055726-22-000043 | 3357 | ||||||
| 2022-06-30 | S-8 | S-8 | 0001193125-22-186278 | 333-265944 | 221058700 | 33 | 317963 | |||
| 2022-05-17 | 8-K | 8-K | 5.02,5.07 | 0001193125-22-153110 | 001-14888 | 22935461 | 34 | 162018 | 1 | 1 |
| 2022-05-17 | 4 | FORM 4 | 0001055726-22-000042 | 11585 | ||||||
| 2022-05-17 | 4 | FORM 4 | 0001055726-22-000041 | 13067 | ||||||
| 2022-05-17 | 4 | FORM 4 | 0001055726-22-000040 | 11346 | ||||||
| 2022-05-17 | 4 | FORM 4 | 0001055726-22-000039 | 12971 | ||||||
| 2022-05-17 | 4 | FORM 4 | 0001055726-22-000038 | 11345 | ||||||
| 2022-05-17 | 4 | FORM 4 | 0001055726-22-000037 | 11416 | ||||||
| 2022-05-17 | 4 | FORM 4 | 0001055726-22-000036 | 11241 | ||||||
| 2022-05-11 | 4 | FORM 4 | 0001055726-22-000035 | 8157 | ||||||
| 2022-05-11 | DEFA14A | DEFA14A | 0001193125-22-147190 | 001-14888 | 22912753 | 34 | 16565 | |||
| 2022-05-10 | 8-K | 8-K | 2.02,5.02,7.01,9.01 | 0001193125-22-146350 | 001-14888 | 22910173 | 34 | 282174 | 1 | 1 |
| 2022-05-10 | 10-Q | 10-Q | 0001055726-22-000034 | 001-14888 | 22909382 | 34 | 8571959 | 1 | 1 | |
| 2022-04-11 | SC 13G/A | Inovio_Pharmaceuticals_Inc.txt | 0000093751-22-000492 | 005-60487 | 22819339 | 34 | 10665 | |||
| 2022-03-28 | 4 | FORM 4 | 0001055726-22-000031 | 8942 | ||||||
| 2022-03-25 | DEF 14A | DEF 14A | 0001055726-22-000030 | 001-14888 | 22771786 | 34 | 4107088 | |||
| 2022-03-22 | 4 | FORM 4 | 0001055726-22-000026 | 7169 | ||||||
| 2022-03-17 | 4 | FORM 4 | 0001055726-22-000025 | 8477 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001055726-22-000024 | 8948 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001055726-22-000023 | 8948 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001055726-22-000022 | 8949 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001055726-22-000021 | 9343 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001055726-22-000020 | 12373 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001055726-22-000019 | 9431 | ||||||
| 2022-03-09 | 4 | FORM 4 | 0001055726-22-000017 | 9420 | ||||||
| 2022-03-09 | 4 | FORM 4 | 0001055726-22-000016 | 12356 | ||||||
| 2022-03-09 | 4 | FORM 4 | 0001055726-22-000015 | 8937 | ||||||
| 2022-03-09 | 4 | FORM 4 | 0001055726-22-000014 | 8865 | ||||||
| 2022-03-01 | 4 | FORM 4 | 0001055726-22-000013 | 11989 | ||||||
| 2022-03-01 | 4 | FORM 4 | 0001055726-22-000012 | 14266 | ||||||
| 2022-03-01 | 4 | FORM 4 | 0001055726-22-000011 | 13778 | ||||||
| 2022-03-01 | 4 | FORM 4 | 0001055726-22-000010 | 13784 | ||||||
| 2022-03-01 | 4 | FORM 4 | 0001055726-22-000009 | 17209 | ||||||
| 2022-03-01 | S-8 | S-8 | 0001193125-22-061610 | 333-263167 | 22699526 | 33 | 68000 | |||
| 2022-03-01 | 10-K | 10-K | 0001055726-22-000008 | 001-14888 | 22697793 | 34 | 16421844 | 1 | 1 | |
| 2022-02-11 | SC 13G/A | INOVIO_PHARMACEUTICALS_INC.txt | 0000093751-22-000264 | 005-60487 | 22618113 | 34 | 8749 | |||
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-017814 | 005-60487 | 22610021 | 34 | 13285 | |||
| 2022-02-01 | SC 13G/A | us45773h2013_020122.txt | 0000834237-22-004599 | 005-60487 | 22580034 | 34 | 13702 | |||
| 2022-01-21 | 4 | FORM 4 | 0001055726-22-000003 | 8477 | ||||||
| 2022-01-18 | 4 | FORM 4 | 0001055726-22-000002 | 7108 | ||||||
| 2022-01-05 | 4 | FORM 4 | 0001055726-22-000001 | 8723 | ||||||
| 2021-11-09 | 424B5 | 424B5 | 0001193125-21-324567 | 333-252256 | 211392919 | 33 | 252280 | |||
| 2021-11-09 | 10-Q | 10-Q | 0001055726-21-000062 | 001-14888 | 211391883 | 34 | 10657486 | 1 | 1 | |
| 2021-10-29 | 8-K | 8-K | 1.02 | 0001193125-21-313502 | 001-14888 | 211364083 | 34 | 146218 | 1 | 1 |
| 2021-10-28 | 8-K | 8-K | 7.01 | 0001193125-21-310286 | 001-14888 | 211354918 | 34 | 145642 | 1 | 1 |
| 2021-08-11 | 4 | FORM 4 | 0001055726-21-000056 | 5436 | ||||||
| 2021-08-09 | 10-Q | 10-Q | 0001055726-21-000055 | 001-14888 | 211156337 | 34 | 10303191 | 1 | 1 | |
| 2021-06-11 | 4 | FORM 4 | 0001055726-21-000052 | 5442 | ||||||
| 2021-06-11 | 4 | FORM 4 | 0001055726-21-000051 | 5436 | ||||||
| 2021-06-11 | 4 | FORM 4 | 0001055726-21-000050 | 9298 | ||||||
| 2021-06-11 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-21-188845 | 001-14888 | 211011217 | 34 | 192468 | 1 | 1 |
| 2021-06-04 | 4 | FORM 4 | 0001055726-21-000049 | 5919 | ||||||
| 2021-05-17 | 4 | FORM 4 | 0001055726-21-000048 | 11413 | ||||||
| 2021-05-17 | 4 | FORM 4 | 0001055726-21-000047 | 12968 | ||||||
| 2021-05-17 | 4 | FORM 4 | 0001055726-21-000046 | 11343 | ||||||
| 2021-05-17 | 4 | FORM 4 | 0001055726-21-000045 | 13065 | ||||||
| 2021-05-17 | 4 | FORM 4 | 0001055726-21-000044 | 12899 | ||||||
| 2021-05-17 | 4 | FORM 4 | 0001055726-21-000043 | 11238 | ||||||
| 2021-05-17 | 4 | FORM 4 | 0001055726-21-000042 | 8207 | ||||||
| 2021-05-17 | 3 | FORM 3 | 0001055726-21-000041 | 3284 | ||||||
| 2021-05-17 | 8-K | 8-K | 5.02,5.07,7.01,9.01 | 0001193125-21-163719 | 001-14888 | 21930980 | 34 | 202516 | 1 | 1 |
| 2021-05-10 | 10-Q | 10-Q | 0001055726-21-000040 | 001-14888 | 21906854 | 34 | 8964433 | 1 | 1 | |
| 2021-04-21 | 4 | FORM 4 | 0001055726-21-000037 | 5919 | ||||||
| 2021-04-21 | 4 | FORM 4 | 0001055726-21-000036 | 10669 | ||||||
| 2021-04-16 | 4 | FORM 4 | 0001055726-21-000035 | 8475 | ||||||
| 2021-03-26 | 4 | FORM 4 | 0001055726-21-000034 | 10506 | ||||||
| 2021-03-25 | DEF 14A | DEF 14A | 0001055726-21-000033 | 001-14888 | 21773537 | 34 | 952717 | |||
| 2021-03-23 | 4 | FORM 4 | 0001055726-21-000030 | 7175 | ||||||
| 2021-03-16 | 4 | FORM 4 | 0001055726-21-000028 | 8479 | ||||||
| 2021-03-12 | 4 | FORM 4 | 0001055726-21-000027 | 9436 | ||||||
| 2021-03-12 | 4 | FORM 4 | 0001055726-21-000026 | 8952 | ||||||
| 2021-03-12 | 4 | FORM 4 | 0001055726-21-000025 | 7166 | ||||||
| 2021-03-12 | 4 | FORM 4 | 0001055726-21-000024 | 12377 | ||||||
| 2021-03-12 | 4 | FORM 4 | 0001055726-21-000023 | 11136 | ||||||
| 2021-03-09 | 4 | FORM 4 | 0001055726-21-000022 | 17897 | ||||||
| 2021-03-09 | 4 | FORM 4 | 0001055726-21-000021 | 14466 | ||||||
| 2021-03-09 | 4 | FORM 4 | 0001055726-21-000020 | 14115 | ||||||
| 2021-03-09 | 4 | FORM 4 | 0001055726-21-000019 | 14951 | ||||||
| 2021-03-01 | S-8 | S-8 | 0001193125-21-063786 | 333-253736 | 21699138 | 33 | 61911 | |||
| 2021-03-01 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-21-063569 | 001-14888 | 21698270 | 34 | 356544 | 1 | 1 |
| 2021-03-01 | 10-K | 10-K | 0001055726-21-000018 | 001-14888 | 21697536 | 34 | 18614587 | 1 | 1 | |
| 2021-02-26 | 4 | FORM 4 | 0001055726-21-000015 | 8086 | ||||||
| 2021-02-26 | 4 | FORM 4 | 0001055726-21-000014 | 7983 | ||||||
| 2021-02-26 | 4 | FORM 4 | 0001055726-21-000013 | 8143 | ||||||
| 2021-02-26 | 4 | FORM 4 | 0001055726-21-000012 | 8185 | ||||||
| 2021-02-26 | 4 | FORM 4 | 0001055726-21-000011 | 8188 | ||||||
| 2021-02-18 | 4 | FORM 4 | 0001055726-21-000009 | 8479 | ||||||
| 2021-02-11 | SC 13G/A | SC 13G/A | 0001140361-21-004328 | 005-60487 | 21619558 | 34 | 72271 | |||
| 2021-02-11 | SC 13G/A | ino221.txt | 0000814133-21-000062 | 005-60487 | 21618855 | 34 | 4264 | |||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-018351 | 005-60487 | 21611086 | 34 | 14150 | |||
| 2021-02-10 | SC 13G | Inovio_Pharmaceuticals_Inc.txt | 0000093751-21-000182 | 005-60487 | 21609444 | 34 | 8765 | |||
| 2021-02-05 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-21-001373 | 005-60487 | 21593353 | 34 | 63478 | |||
| 2021-02-03 | 4 | FORM 4 | 0001055726-21-000008 | 13875 | ||||||
| 2021-02-03 | 4 | FORM 4 | 0001055726-21-000007 | 10684 | ||||||
| 2021-01-29 | 4 | FORM 4 | 0001055726-21-000005 | 15928 | ||||||
| 2021-01-29 | SC 13G/A | us45773h2013_012921.txt | 0000834237-21-003989 | 005-60487 | 21568845 | 34 | 13683 | |||
| 2021-01-22 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-21-014758 | 001-14888 | 21546024 | 34 | 450227 | 1 | 1 |
| 2021-01-22 | 424B5 | 424B5 | 0001193125-21-014750 | 333-252256 | 21546008 | 33 | 624204 | |||
| 2021-01-20 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-21-012455 | 001-14888 | 21539042 | 34 | 427476 | 1 | 1 |
| 2021-01-20 | 424B5 | 424B5 | 0001193125-21-012445 | 333-252256 | 21539008 | 33 | 616239 | |||
| 2021-01-20 | S-3ASR | S-3ASR | 0001193125-21-012393 | 333-252256 | 21538773 | 33 | 188437 | |||
| 2021-01-15 | 4 | FORM 4 | 0001055726-21-000004 | 9540 | ||||||
| 2021-01-15 | 4 | FORM 4 | 0001055726-21-000003 | 7113 | ||||||
| 2021-01-05 | 4 | FORM 4 | 0001055726-21-000002 | 8732 | ||||||
| 2021-01-05 | 4 | FORM 4 | 0001055726-21-000001 | 8475 | ||||||
| 2021-01-04 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-21-000955 | 001-14888 | 21501904 | 34 | 203370 | 1 | 1 |
| 2020-12-31 | 4 | FORM 4 | 0001055726-20-000057 | 8491 | ||||||
| 2020-12-17 | 4 | FORM 4 | 0001055726-20-000056 | 13029 | ||||||
| 2020-12-17 | 4 | FORM 4 | 0001055726-20-000055 | 8963 | ||||||
| 2020-12-07 | 4 | FORM 4 | 0001055726-20-000054 | 7002 | ||||||
| 2020-11-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-294751 | 001-14888 | 201316773 | 34 | 188412 | 1 | 1 |
| 2020-11-12 | 4 | FORM 4 | 0001055726-20-000053 | 5436 | ||||||
| 2020-11-09 | 10-Q | 10-Q | 0001055726-20-000052 | 001-14888 | 201297475 | 34 | 10699726 | 1 | 1 | |
| 2020-10-15 | 8-K | 8-K | 1.02 | 0001193125-20-270257 | 001-14888 | 201241530 | 34 | 145377 | 1 | 1 |
| 2020-09-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-256781 | 001-14888 | 201205406 | 34 | 179623 | 1 | 1 |
| 2020-09-03 | 8-K | 8-K | 5.02 | 0001193125-20-239111 | 001-14888 | 201159731 | 34 | 154903 | 1 | 1 |
| 2020-08-12 | 4 | FORM 4 | 0001055726-20-000049 | 5441 | ||||||
| 2020-08-10 | 10-Q | 10-Q | 0001055726-20-000048 | 001-14888 | 201089118 | 34 | 10483107 | 1 | 1 | |
| 2020-07-31 | 4 | FORM 4 | 0001055726-20-000045 | 8860 | ||||||
| 2020-07-17 | 4 | FORM 4 | 0001055726-20-000044 | 9540 | ||||||
| 2020-07-02 | 4 | FORM 4 | 0001055726-20-000043 | 5923 | ||||||
| 2020-06-25 | 8-K | 8-K | 1.01,7.01,8.01,9.01 | 0001193125-20-179128 | 001-14888 | 20989850 | 34 | 60183 | ||
| 2020-06-24 | 4 | FORM 4 | 0001055726-20-000042 | 4968 | ||||||
| 2020-06-03 | 8-K | 8-K | 8.01 | 0001193125-20-159486 | 001-14888 | 20939950 | 34 | 23588 | ||
| 2020-05-20 | 4 | FORM 4 | 0001055726-20-000040 | 8748 | ||||||
| 2020-05-18 | 8-K | 8-K | 5.07 | 0001193125-20-145017 | 001-14888 | 20889529 | 34 | 28617 | ||
| 2020-05-15 | 4 | FORM 4 | 0001055726-20-000039 | 7794 | ||||||
| 2020-05-15 | 4 | FORM 4 | 0001055726-20-000038 | 7856 | ||||||
| 2020-05-15 | 4 | FORM 4 | 0001055726-20-000037 | 7854 | ||||||
| 2020-05-15 | 4 | FORM 4 | 0001055726-20-000036 | 7785 | ||||||
| 2020-05-15 | 4 | FORM 4 | 0001055726-20-000035 | 7681 | ||||||
| 2020-05-15 | 4 | FORM 4 | 0001055726-20-000034 | 7786 | ||||||
| 2020-05-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-140512 | 001-14888 | 20869596 | 34 | 34645 | ||
| 2020-05-12 | 4 | FORM 4 | 0001055726-20-000033 | 5027 | ||||||
| 2020-05-12 | 424B5 | 424B5 | 0001193125-20-140456 | 333-237172 | 20869418 | 33 | 367042 | |||
| 2020-05-11 | 10-Q | 10-Q | 0001055726-20-000032 | 001-14888 | 20864609 | 34 | 6932894 | 1 | ||
| 2020-05-08 | 4 | FORM 4 | 0001055726-20-000029 | 6859 | ||||||
| 2020-05-08 | 4 | FORM 4 | 0001055726-20-000028 | 6928 | ||||||
| 2020-05-08 | 4 | FORM 4 | 0001055726-20-000027 | 6755 | ||||||
| 2020-05-08 | 4 | FORM 4 | 0001055726-20-000026 | 6869 | ||||||
| 2020-05-08 | 4 | FORM 4 | 0001055726-20-000025 | 6930 | ||||||
| 2020-05-08 | 4 | FORM 4 | 0001055726-20-000024 | 6853 | ||||||
| 2020-05-01 | UPLOAD | filename1.pdf | 0000000000-20-003771 | 39987 | ||||||
| 2020-04-24 | CORRESP | filename1.htm | 0001193125-20-119137 | 24441 | ||||||
| 2020-04-15 | DEFA14A | DEFA14A | 0001193125-20-108190 | 001-14888 | 20794352 | 34 | 46248 | |||
| 2020-04-14 | UPLOAD | filename1.pdf | 0000000000-20-003215 | 43121 | ||||||
| 2020-04-06 | 8-K | FORM 8-K | 8.01 | 0001193125-20-099003 | 001-14888 | 20775854 | 34 | 19037 | ||
| 2020-04-03 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-20-098305 | 001-14888 | 20774501 | 34 | 178742 | ||
| 2020-04-03 | 424B5 | 424B5 | 0001193125-20-098301 | 333-237172 | 20774468 | 33 | 377045 | |||
| 2020-03-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-03-31 16:00:00 | 9999999995-20-000654 | 333-237172 | 20763609 | 33 | 1996 | ||
| 2020-03-27 | CORRESP | filename1.htm | 0001193125-20-088806 | 21092 | ||||||
| 2020-03-27 | DEF 14A | DEF 14A | 0001055726-20-000022 | 001-14888 | 20751779 | 34 | 991399 | |||
| 2020-03-26 | 4 | FORM 4 | 0001055726-20-000019 | 8952 |
One latest value per concept from companyfacts (441 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 187.31M | 2026-11-10 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 74.30M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 833,484 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001055726-26-000011 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 872,160 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001055726-26-000011 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 9.29 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-07 | 0001055726-26-000011 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 36,318.61 | 2026-06-30 | S-3 | 2026-07-02 | 0001193125-26-294457 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 36,318.61 | 2026-06-30 | S-3 | 2026-07-02 | 0001193125-26-294457 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 300.00M | 2026-06-30 | S-3 | 2026-07-02 | 0001193125-26-294457 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-06-30 | S-3 | 2026-07-02 | 0001193125-26-294457 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-06-30 | S-3 | 2026-07-02 | 0001193125-26-294457 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 24.75M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent | Accounts Payable and Accrued Liabilities | USD | 23.13M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 | |
| us-gaap | AccountsPayableTradeCurrentAndNoncurrent | Accounts Payable, Trade | USD | 11.19M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 450 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | AccountsReceivableRelatedPartiesCurrent | Accounts Receivable, Related Parties, Current | USD | 4.96M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 4.50M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001055726-19-000058 | |
| us-gaap | AccruedLiabilitiesForCommissionsExpenseAndTaxes | Accrued Liabilities for Commissions, Expense and Taxes | USD | 162.10M | 2021-01-25 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001055726-21-000062 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 177,810 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 7.61M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 17.42M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 | Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment | USD | 89,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -267,070 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.86B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | USD | 15.75M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 868,002 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 3.03M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 99.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | Assets | Assets | USD | 60.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 51.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 16.34M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 2,534 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 28,319 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 1.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 2.33M | 2017-12-31 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001055726-18-000045 | |
| us-gaap | AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2017-12-31 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001055726-18-000045 | |
| us-gaap | AvailableForSaleEquitySecuritiesAmortizedCostBasis | Available-for-sale Equity Securities, Amortized Cost Basis | USD | 0 | 2015-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001055726-19-000052 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 105.96M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 2.37M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 392,571 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 103.99M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Loss (Deprecated 2018-01-31) | USD | 108,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 1.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecurities | Available-for-sale Securities, Equity Securities | USD | 2.33M | 2017-12-31 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001055726-18-000045 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecuritiesNoncurrent | Available-for-sale Securities, Equity Securities, Noncurrent | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-15 | 0001055726-17-000013 | |
| us-gaap | AvailableForSaleSecuritiesFairValueDisclosure | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | USD | 13.11M | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-09 | 0001055726-13-000008 | |
| us-gaap | AvailableforsaleSecuritiesGrossUnrealizedGain | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | USD | 0 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-09 | 0001055726-13-000008 | |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLosses1 | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | USD | 84,185 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-09 | 0001055726-13-000008 | |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | investment | 42 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 | |
| us-gaap | AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear | Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year | investment | 16 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 | |
| us-gaap | Capital | Banking Regulation, Total Capital, Actual | USD | 255.30M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001055726-22-000055 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001055726-26-000023 |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 1.61M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-15 | 0001193125-12-117292 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 46.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -92,946 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 48.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 46.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 2.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | CashDivestedFromDeconsolidation | Cash Divested from Deconsolidation | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | USD/warrant | 1.4 | 2011-01-31 | 2013 | FY | 10-K | 2014-03-17 | 0001055726-14-000003 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 1.4 | 2026-04-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 94.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 600.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 110.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 110.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 110,182 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -74.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -110.17M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001055726-23-000055 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | ConvertibleDebt | Convertible Debt | USD | 16.30M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001055726-22-000055 | |
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 | |
| us-gaap | ConvertibleDebtNoncurrent | Convertible Debt, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | CostMethodInvestmentsFairValueDisclosure | Cost Method Investments, Fair Value Disclosure | USD | 2.33M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 | |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 0 | 2018-01-01 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent | Debt Instrument, Convertible, Carrying Amount of Equity Component | USD | 62.20M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 | |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 5.38 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 | |
| us-gaap | DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 | Debt Instrument, Convertible, Threshold Consecutive Trading Days | day | 30 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 |
| us-gaap | DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | pure | 1.3 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-10 | 0001055726-20-000048 |
| us-gaap | DebtInstrumentConvertibleThresholdTradingDays | Debt Instrument, Convertible, Threshold Trading Days | day | 20 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.131 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | DebtInstrumentRedemptionPricePercentage | Debt Instrument, Redemption Price, Percentage | pure | 1 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 18.60M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 31,000 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001055726-19-000029 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 560,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | position | 19 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0001055726-24-000046 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGain | Debt Securities, Available-for-sale, Realized Gain | USD | 400 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 238,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001055726-19-000058 |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedLoss | Debt Securities, Available-for-sale, Realized Loss | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | position | 2 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | DeconsolidationGainOrLossAmount | Deconsolidation, Gain (Loss), Amount | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 2.80M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 1.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 2.40M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 651,505 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 203,322 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 | |
| us-gaap | DeferredTaxAssetsDerivativeInstruments | Deferred Tax Assets, Derivative Instruments | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 379.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 40.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsInvestments | Deferred Tax Assets, Investments | USD | 1.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 1.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-14 | 0001055726-16-000033 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 293.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 5.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsOtherTaxCarryforwards | Deferred Tax Assets, Other Tax Carryforwards | USD | 33.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 635,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 378.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | DeferredTaxLiabilitiesFinancingArrangements | Deferred Tax Liabilities, Financing Arrangements | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates | Deferred Tax Liabilities, Investment in Noncontrolled Affiliates | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 174,793 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001055726-17-000036 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.06 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | DepositsAssetsCurrent | Deposits Assets, Current | USD | 50.00M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 | |
| us-gaap | Depreciation | Depreciation | USD | 960,912 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001055726-20-000052 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 70.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 | |
| us-gaap | DilutiveSecurities | Dilutive Securities, Effect on Basic Earnings Per Share | USD | -116,477 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-10 | 0001055726-17-000024 |
| us-gaap | DilutiveSecuritiesEffectOnBasicEarningsPerShareOther | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities | USD | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001055726-20-000052 |
| us-gaap | DueFromRelatedPartiesCurrent | Due from Related Parties, Current | USD | 134,320 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-07 | 0001193125-12-457586 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 1.42M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.9 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.27 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001055726-21-000040 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.9 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.194 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.012 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.018 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.032 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-15 | 0001055726-17-000013 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 2.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.2 | 2015-06-30 | 2016 | Q2 | 10-Q | 2016-08-08 | 0001055726-16-000062 | |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 | |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 2.10M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | EquitySecuritiesFvNiCurrentAndNoncurrent | EquitySecuritiesFvNiCurrentAndNoncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | EquitySecuritiesFvNiUnrealizedGain | Equity Securities, FV-NI, Unrealized Gain | USD | 625,000 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001055726-21-000062 |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | 302,606 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | EquitySecuritiesFvNiUnrealizedLoss | Equity Securities, FV-NI, Unrealized Loss | USD | 10.60M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001055726-22-000055 |
| us-gaap | EstimatedInsuranceRecoveries | Estimated Insurance Recoveries | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 8.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | FairValueAssumptionsExpectedDividendPayments | Fair Value Assumptions, Expected Dividend Payments (Deprecated 2018-01-31) | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | FairValueAssumptionsExpectedVolatilityRate | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | pure | 0.65 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | FairValueAssumptionsRiskFreeInterestRate | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | pure | 0.019 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | USD | -2.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 2.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings | USD | 8.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances | USD | 16.06M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | 84.49M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 11.42M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001055726-25-000055 | |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 70.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 7.17M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 845,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 253,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 190,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 253,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 253,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 253,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 253,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 9.15M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 0 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001055726-17-000039 |
| us-gaap | GainLossOnDispositionOfIntangibleAssets | Gain (Loss) on Disposition of Intangible Assets | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 153,252 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-09 | 0001055726-21-000055 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 1.14M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-15 | 0001193125-12-117292 |
| us-gaap | GainLossOnSaleOfOtherInvestments | Gain (Loss) on Sale of Other Investments | USD | -1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | GainsLossesOnSalesOfAssets | Gain (Loss) on Disposition of Assets for Financial Service Operations | USD | 501,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-16 | 0001055726-15-000003 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 24.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | Goodwill | Goodwill | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 12.50M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | GoodwillGross | Goodwill, Gross | USD | 10.51M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 0 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -84.95M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -84.95M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -135.12M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | 30,000 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 16.48M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 403,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -17.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 536,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 118,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -410,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 1.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.74M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 2.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | 859,354 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001055726-22-000034 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -220,466 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001055726-25-000063 |
| us-gaap | IncreaseDecreaseInAccountsReceivableRelatedParties | Increase (Decrease) in Accounts Receivable, Related Parties | USD | 2.06M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -1.17M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001055726-19-000058 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | IncreaseDecreaseInDeferredIncomeTaxes | Increase (Decrease) in Deferred Income Taxes | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | IncreaseDecreaseInDeferredRentReceivables | Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) | USD | 215 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-09 | 0001193125-12-222402 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 651,505 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-09 | 0001055726-21-000055 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 261,325 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -95,406 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 469,496 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-15 | 0001055726-17-000013 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 920,891 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | InterestExpense | Interest Expense | USD | 177,833 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0001055726-24-000020 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | InterestExpenseOperating | InterestExpenseOperating | USD | 177,833 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0001055726-24-000046 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | -169,300 | 2018-10-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 |
| us-gaap | InterestIncomeOperating | Interest Income, Operating | USD | 2.81M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0001055726-24-000046 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | InvestmentIncomeAmortizationOfPremium | Investment Income, Amortization of Premium | USD | 125,810 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001055726-22-000034 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 18,094 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | InvestmentOwnedAtFairValue | Investment Owned, at Fair Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures | Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | USD | 6.32M | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001055726-19-000052 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 1.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 1.80M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001055726-13-000011 | |
| us-gaap | LeaseIncentiveReceivable | Lease Incentive Receivable | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 8.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 2.13M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 3.25M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 2.13M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 2.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 905,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | Liabilities | Liabilities | USD | 94.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 60.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 89.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 6.16M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-07 | 0001193125-12-457586 | |
| us-gaap | LicensesRevenue | Licenses Revenue (Deprecated 2018-01-31) | USD | 1.29M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | LineOfCreditFacilityIncreaseAccruedInterest | Line of Credit Facility, Increase, Accrued Interest | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-15 | 0001055726-17-000013 |
| us-gaap | LitigationReserveCurrent | Estimated Litigation Liability, Current | USD | 0 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 62.76M | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-08 | 0001055726-19-000052 | |
| us-gaap | LongTermDebtFairValue | Long-term Debt, Fair Value | USD | 62.20M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 21.20M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001055726-20-000032 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 80,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-09 | 0001055726-15-000015 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 83.18M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001055726-18-000040 | |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 | |
| us-gaap | MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders | USD | 149,559 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | MinorityInterestDecreaseFromRedemptions | Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests | USD | 0 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | MinorityInterestOwnershipPercentageByNoncontrollingOwners | Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners | pure | 0.15 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001055726-18-000040 | |
| us-gaap | MinorityInterestOwnershipPercentageByParent | Noncontrolling Interest, Ownership Percentage by Parent | pure | 0.85 | 2014-05-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 45.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 12.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -54.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -74.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | NetIncomeLossAttributableToParentDiluted | Net Income (Loss) Attributable to Parent, Diluted | USD | -196.71M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001055726-21-000062 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -119.36M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -142.07M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001055726-20-000052 |
| us-gaap | NoncontrollingInterestDecreaseFromDeconsolidation | Noncontrolling Interest, Decrease from Deconsolidation | USD | 3.18M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | NoncontrollingInterestIncreaseFromBusinessCombination | Noncontrolling Interest, Increase from Business Combination | USD | 670,307 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-15 | 0001193125-12-117292 |
| us-gaap | NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance | Noncontrolling Interest, Increase from Subsidiary Equity Issuance | USD | 2.38M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 60.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -60.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 7.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 5.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 35.65M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 3.76M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 4.02M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 4.05M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 3.98M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 3.89M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 15.95M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 831,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001055726-18-000045 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 3.20M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | OperatingLeasesRentExpenseSubleaseRentals1 | Operating Leases, Rent Expense, Sublease Rentals | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.09 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 5.95M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0001055726-23-000030 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) | USD | 495 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-09 | 0001193125-12-222402 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | 335,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001055726-19-000058 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 370,893 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrent | Other Employee-related Liabilities, Current | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 261,325 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -5.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 2.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings | USD | 36,000 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001055726-19-000029 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities | Other than Temporary Impairment Losses, Investments, Available-for-sale Securities | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net | USD | 253,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | PaymentsForDeposits | Payments for Deposits | USD | 30.00M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | PaymentsForProceedsFromInvestments | Payments for (Proceeds from) Investments | USD | -40.13M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001055726-20-000052 |
| us-gaap | PaymentsOfCapitalDistribution | Payments of Capital Distribution | USD | 1.00M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 531,000 | 2021-01-01 | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001055726-22-000034 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 466,646 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001055726-23-000055 |
| us-gaap | PaymentsToAcquireAdditionalInterestInSubsidiaries | Payments to Acquire Additional Interest in Subsidiaries | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | PaymentsToAcquireInterestInSubsidiariesAndAffiliates | Payments to Acquire Interest in Subsidiaries and Affiliates | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-17 | 0001055726-14-000003 |
| us-gaap | PaymentsToAcquireOtherInvestments | Payments to Acquire Other Investments | USD | 101,123 | 2011-01-01 | 2011-09-30 | 2012 | Q3 | 10-Q | 2012-11-07 | 0001193125-12-457586 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 1.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | PaymentsToMinorityShareholders | Payments to Noncontrolling Interests | USD | 0 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001055726-17-000039 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 9 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 9 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 273,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001055726-22-000055 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 81.90M | 2015-05-01 | 2015-05-31 | 2016 | FY | 10-K | 2017-03-15 | 0001055726-17-000013 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 7.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 33.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 21.00M | 2026-07-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments | Proceeds from Maturities, Prepayments and Calls of Short-term Investments | USD | 2.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ProceedsFromMinorityShareholders | Proceeds from Noncontrolling Interests | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 |
| us-gaap | ProceedsFromSaleOfEquityMethodInvestments | Proceeds from Sale of Equity Method Investments | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001055726-21-000062 |
| us-gaap | ProceedsFromSaleOfEquitySecuritiesFvNi | ProceedsFromSaleOfEquitySecuritiesFvNi | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | ProceedsFromSaleOfIntangibleAssets | Proceeds from Sale of Intangible Assets | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 650,000 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-07 | 0001193125-12-457586 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 12.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 823 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 3.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -279.82M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 |
| us-gaap | PropertyPlantAndEquipmentDisposals | Property, Plant and Equipment, Disposals | USD | 37,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 19.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 1.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 47.40M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 | |
| us-gaap | RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty | Related Party Transaction, Other Revenues from Transactions with Related Party | USD | 2.57M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | RepaymentsOfLinesOfCredit | Repayments of Lines of Credit | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-18 | 0001445305-13-000665 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 35.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-16 | 0001055726-15-000003 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 2.20M | 2019-07-01 | 2019-09-30 | 2019 | FY | 10-K | 2020-03-12 | 0001055726-20-000012 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.89B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 298,901 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 92,590 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | Revenues | Revenues | USD | 1.53M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001055726-18-000026 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001055726-22-000008 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 27.60M | 2024-12-16 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 12.50M | 2026-04-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 0.95 | 2026-07-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 42.22M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-14 | 0001055726-18-000014 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 64,000 | 2013-04-30 | 2013 | Q3 | 10-Q | 2013-11-12 | 0001055726-13-000011 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 2.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.31 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-07 | 0001193125-12-457586 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.019 | 2011-01-01 | 2011-09-30 | 2012 | Q3 | 10-Q | 2012-11-07 | 0001193125-12-457586 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.004 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-07 | 0001193125-12-457586 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares | 284,091 | 2018-07-01 | 2018-09-30 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 1.92M | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-09 | 0001193125-12-347489 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 100 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 40,736 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 77,563 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 67.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 763,990 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.27 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 28.05 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.98 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 91.31 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 2.02 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | USD/shares | 42.81 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 1.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 2.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | USD/shares | 28.05 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 8.41 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001055726-17-000036 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 1.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -33.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 222.36M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001055726-23-000010 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.083 | 2024-01-24 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 20.36M | 2021-01-25 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001055726-21-000062 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 416 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 4.30M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-12 | 0001055726-19-000012 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 4.38M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0001055726-24-000011 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | USD | 4.83M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-03-15 | 0001193125-12-117292 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 14.00M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0001055726-25-000012 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 3.01M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | -811 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 168,665 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-03-15 | 0001193125-12-117292 |
| us-gaap | StraightLineRent | Straight Line Rent | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001055726-21-000018 |
| us-gaap | TenantImprovements | Tenant Improvements | USD | 933,000 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001055726-17-000036 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -28,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 26.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 201,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 1.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 197,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 24.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001055726-26-000008 | |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 70.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 | |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0001055726-21-000062 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 83.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 202.41M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001055726-21-000040 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 83.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001055726-26-000029 |